This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Schering Corporation. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Michael R Ziebell: Innovator in PCSK9 Inhibitors
Introduction
Michael R Ziebell is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of methods for identifying modulators of PCSK9. His work is crucial for advancing treatments for diseases such as hyperlipidemia and related disorders.
Latest Patents
Ziebell holds a patent for an "Assay for PCSK9 inhibitors." This invention provides methods for identifying modulators of PCSK9 using various assay formats. The inhibitors developed through this research have the potential to treat conditions associated with high cholesterol levels.
Career Highlights
Michael R Ziebell is associated with Schering Corporation, where he has been instrumental in research and development. His expertise in biochemistry and pharmacology has led to advancements in therapeutic options for patients suffering from lipid disorders.
Collaborations
Ziebell has collaborated with notable colleagues, including Andrew Joseph Prongay and Thomas E Hesson. These partnerships have fostered innovation and contributed to the success of their projects.
Conclusion
Michael R Ziebell's work in the field of PCSK9 inhibitors exemplifies the impact of innovative research on healthcare. His contributions continue to pave the way for new treatments and improved patient outcomes.